Gain the latest insights from our cross-functional Advisory experts on: 

• Evolving US vaccine landscape – With recent federal actions leading to shifts in the Advisory Committee on Immunization Practices (ACIP) and immunization policies within the US, Avalere Health will explore the latest trends and policy changes impacting implementation, coverage and uptake which shape vaccine access, development and distribution 

• Evaluation of evidentiary needs & considerations for recommendation – With increasing scrutiny of professional societies and guideline bodies in US and ex-US markets, Avalere Health can discuss evolving expectations of trial design, study endpoints, and other key factors influencing data collection and evidence appraisal efforts that inform recommendation development across various markets. 

• Strategic planning through NITAG processes – Leveraging what is understood about evidentiary expectations among key stakeholders, Avalere Health can support strategic engagement planning as it relates to regulatory, policy and payer group, to identify best practices for navigating evidence packages (i.e., NITAG dossiers, global value dossiers, scientific narratives) to optimize vaccine adoption and use. 

• Economic modeling – Avalere Health can assist with insight-gathering and even support development early and late-phase cost-effectiveness analyses (CEA), as well as budgetary impact analyses, to evaluate vaccine value propositions for payers, policymakers, and guideline bodies. 

• Depth and breadth of infectious disease experience – Avalere Health has experts with decades of experience across infectious disease areas including but not limited to respiratory and latent viruses, those impacting pediatric and/or adult populations, and preventable infectious that can perpetuate or exacerbate existing chronic conditions. Further, Avalere Health is well-versed in the unique innovations that may share characteristics of vaccines and drugs alike and has the demonstrated ability to consider the critical environmental considerations necessary for the appropriate review and use of such products. 

Avalere Health Attendees: 

• Elif Alyanak, Principal, Advisory
• Christina Gramling, Consultant II, Advisory
• Sophia Lopez, Consultant II, Advisory